SHIFT Newsroom · GLOBAL
Response after switching medicines reported in one patient
A JCEM Case Reports article describes one man who lost more weight after switching from tirzepatide to semaglutide.
A JCEM Case Reports article describes one man who lost more weight after switching from tirzepatide to semaglutide. This is a single-patient observation, not a comparative trial or evidence for a general switching rule. The proposed biological explanations remain hypotheses. Treatment response and any change of medicine require an individual prescriber review.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.